OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 363-374
Open Access | Times Cited: 48
Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 363-374
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine
Madeline E. Kavanagh, Benjamin D. Horning, Roli Khattri, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 12, pp. 1388-1398
Open Access | Times Cited: 57
Madeline E. Kavanagh, Benjamin D. Horning, Roli Khattri, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 12, pp. 1388-1398
Open Access | Times Cited: 57
Alopecia Areata: Current Treatments and New Directions
Dante Dahabreh, Seungyeon Jung, Yael Renert‐Yuval, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 895-912
Closed Access | Times Cited: 39
Dante Dahabreh, Seungyeon Jung, Yael Renert‐Yuval, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 895-912
Closed Access | Times Cited: 39
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
Andreas Papapetropoulos, Stavros Topouzis, S P H Alexander, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 11, pp. 1553-1575
Open Access | Times Cited: 12
Andreas Papapetropoulos, Stavros Topouzis, S P H Alexander, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 11, pp. 1553-1575
Open Access | Times Cited: 12
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
Anas Saadeddin, Vivek S. Purohit, Yeamin Huh, et al.
The AAPS Journal (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 9
Anas Saadeddin, Vivek S. Purohit, Yeamin Huh, et al.
The AAPS Journal (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 9
Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
Yuan Zhou, Yu-Xuan Zhang, Yuyun Xiong, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 1
Yuan Zhou, Yu-Xuan Zhang, Yuyun Xiong, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 1
Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
Jair Alejandro Valdez-Zertuche, Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access | Times Cited: 1
Jair Alejandro Valdez-Zertuche, Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access | Times Cited: 1
Organic NMR crystallography: enabling progress for applications to pharmaceuticals and plant cell walls
Zainab Rehman, Jairah Lubay, W. Trent Franks, et al.
Faraday Discussions (2024)
Open Access | Times Cited: 7
Zainab Rehman, Jairah Lubay, W. Trent Franks, et al.
Faraday Discussions (2024)
Open Access | Times Cited: 7
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 7
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 7
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
Aditya K. Gupta, Tong Wang, Shruthi Polla Ravi, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 4, pp. 666-679
Closed Access | Times Cited: 26
Aditya K. Gupta, Tong Wang, Shruthi Polla Ravi, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 4, pp. 666-679
Closed Access | Times Cited: 26
Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases
Tong Li, Xianjing Yang, Juan Zhu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110660-110660
Closed Access | Times Cited: 13
Tong Li, Xianjing Yang, Juan Zhu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110660-110660
Closed Access | Times Cited: 13
Novel investigational drugs for alopecia areata and future perspectives
Ivana Chim, Ragini Ghiya, Rodney Sinclair, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 441-449
Closed Access | Times Cited: 4
Ivana Chim, Ragini Ghiya, Rodney Sinclair, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 441-449
Closed Access | Times Cited: 4
Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
Mohammad I. Fatani, Abdullah Alkhalifah, Amaal Farhan Salman Alruwaili, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 10, pp. 2129-2151
Open Access | Times Cited: 10
Mohammad I. Fatani, Abdullah Alkhalifah, Amaal Farhan Salman Alruwaili, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 10, pp. 2129-2151
Open Access | Times Cited: 10
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management
Giovanni Paolino, Mario Valenti, Andrea Carugno, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 54-54
Open Access
Giovanni Paolino, Mario Valenti, Andrea Carugno, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 54-54
Open Access
Modern Management Approaches for Alopecia Areata
Eduard Т. Ambarchian, Vladislav V. Ivanchikov, Anastasia D. Kuzminova, et al.
Вопросы современной педиатрии (2025) Vol. 23, Iss. 6, pp. 516-522
Open Access
Eduard Т. Ambarchian, Vladislav V. Ivanchikov, Anastasia D. Kuzminova, et al.
Вопросы современной педиатрии (2025) Vol. 23, Iss. 6, pp. 516-522
Open Access
A Medicinal Chemistry Perspective on FDA-Approved Small Molecule Drugs with a Covalent Mechanism of Action
Samuel E. Dalton, Ornella Di Pietro, Elisabeth T. Hennessy
Journal of Medicinal Chemistry (2025)
Closed Access
Samuel E. Dalton, Ornella Di Pietro, Elisabeth T. Hennessy
Journal of Medicinal Chemistry (2025)
Closed Access
Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
Samah Omar Ali Alfahl, Abdullateef A. Alzolibani
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1817-1817
Open Access
Samah Omar Ali Alfahl, Abdullateef A. Alzolibani
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1817-1817
Open Access
Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
Andrea Pagani, Dominik Thor, Adriana C. Panayi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2133-2133
Open Access
Andrea Pagani, Dominik Thor, Adriana C. Panayi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2133-2133
Open Access
Development of a Rapid LC‐MS/MS Method and Its Application for the Pharmacokinetic Analysis of Pacritinib in Rats
Ya Wu, Kai Zheng, Luo yi Huang, et al.
Journal of Mass Spectrometry (2025) Vol. 60, Iss. 5
Open Access
Ya Wu, Kai Zheng, Luo yi Huang, et al.
Journal of Mass Spectrometry (2025) Vol. 60, Iss. 5
Open Access
Dermatological Indications: Alopecia Areata
Muazzez Çiğdem Oba, Zekayі Kutlubay
(2025), pp. 83-92
Closed Access
Muazzez Çiğdem Oba, Zekayі Kutlubay
(2025), pp. 83-92
Closed Access
Treatment Options for Alopecia Areata in Children and Adolescents
Linnea Westerkam, Diana B. McShane, Elizabeth L. Nieman, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 3, pp. 245-257
Closed Access | Times Cited: 3
Linnea Westerkam, Diana B. McShane, Elizabeth L. Nieman, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 3, pp. 245-257
Closed Access | Times Cited: 3
Evaluation of the effect of ritlecitinib on the pharmacokinetics of caffeine in healthy participants
Jian Liu, Rohit Solan, Robert Wołk, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 7, pp. 2208-2215
Open Access | Times Cited: 8
Jian Liu, Rohit Solan, Robert Wołk, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 7, pp. 2208-2215
Open Access | Times Cited: 8
Emerging drugs for the treatment of alopecia areata
Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 4, pp. 379-387
Closed Access | Times Cited: 12
Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 4, pp. 379-387
Closed Access | Times Cited: 12
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
Samira Anderson, Guido Cavaletti, Linda J. Hood, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Samira Anderson, Guido Cavaletti, Linda J. Hood, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
A. Premanand, Baskaran Reena Rajkumari
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6
A. Premanand, Baskaran Reena Rajkumari
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6
